Moreover, the inflammatory environment of the bronchoalveolar system in patients with asthma could result in a decrease in the expression of the ACE-2, a known SARS-CoV-2 binding receptor, due to IL-13 eosinophil recruitment. Here, ACE2 is linked to asthma.